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 Characterization of carrier erythrocytes for
biosensing applications
Sandra C. Bustamante Lópeza and Kenith E. Meissnera,b,*
aTexas A&M University, College of Engineering, Department of Biomedical Engineering, College Station, Texas, United States
bSwansea University, Department of Physics, Swansea, Wales, United Kingdom
Abstract. Erythrocytes’ abundance, mobility, and carrying capacity make them attractive as a platform for blood
analyte sensing as well as for drug delivery. Sensor-loaded erythrocytes, dubbed erythrosensors, could be rein-
fused into the bloodstream, excited noninvasively through the skin, and used to provide measurement of analyte
levels in the bloodstream. Several techniques to load erythrocytes, thus creating carrier erythrocytes, exist.
However, their cellular characteristics remain largely unstudied. Changes in cellular characteristics lead to
removal from the bloodstream. We hypothesize that erythrosensors need to maintain native erythrocytes’
(NEs) characteristics to serve as a long-term sensing platform. Here, we investigate two loading techniques
and the properties of the resulting erythrosensors. For loading, hypotonic dilution requires a hypotonic solution
while electroporation relies on electrical pulses to perforate the erythrocyte membrane. We analyze the resulting
erythrosensor signal, size, morphology, and hemoglobin content. Although the resulting erythrosensors exhibit
morphological changes, their size was comparable with NEs. The hypotonic dilution technique was found to load
erythrosensors much more efficiently than electroporation, and the sensors were loaded throughout the volume
of the erythrosensors. Finally, both techniques resulted in significant loss of hemoglobin. This study points to the
need for continued development of loading techniques that better preserve NE characteristics. © 2017 Society of
Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.22.9.XXXXXX]
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1 Introduction
Diabetes and other debilitating conditions are diagnosed,
treated, and monitored by blood sampling. For diabetics, diet,
insulin regulation, and glucose monitoring ameliorate serious
complications. The primary devices for glucose monitoring, fin-
ger stick-based glucose meters, suffer from issues, such as
human error and meter/strip quality as well as being susceptible
to interfering factors.1–3 Poor control of blood glucose levels can
result in complications affecting the eyes, heart, kidneys, nerves,
and feet.4 In addition, development of hypoglycemia or hyper-
glycemia can lead to death. Finger pricking multiple times
throughout the day hinders the accurate identification of trends,
reduces compliance, and increases the risk of complications.3,4
Thus, there is an urgent need to explore continuous blood ana-
lyte sensing.
Continuous glucose monitoring systems (CGMS) have lim-
ited sensing lifetime and must address immunogenicity, selec-
tivity, and biodegradation issues. Current CGMS have
lifetimes on the order of 10 days and require frequent recalibra-
tion, often using a standard finger prick.5–7 In addition, implant-
able CGMS can trigger undesirable immune response, resulting
in fibrotic tissue separating the device from blood vessels and
surrounding tissue. This separation can lead to inaccuracy, a
shorter lifetime, and niches susceptible to infection.8,9 Hence,
new monitoring methods must be investigated.
Erythrocytes functionalized with optical sensors, or erythro-
sensors, could address the need for a biocompatible, long-term
monitoring platform. This approach to blood analyte monitoring
relies on isolating erythrocytes, loading them with fluorescent
sensors, and injecting the erythrosensors into circulation for ana-
lyte monitoring.10,11 The erythrosensors’ fluorescent signal can
be excited and detected noninvasively through the skin. With the
goal of developing erythrosensors, erythrocyte functionaliza-
tion, or loading, must conserve features such as shape, surface
morphology, size, and hemoglobin content.
Native erythrocytes (NEs) preserve key properties, such as
volume and hemoglobin content as they alter shape to transit
the circulatory system. Bovine erythrocytes measure around
5 μm in diameter and have a life span of 160 days, whereas
human erythrocytes are around 8 μm in diameter and have a
life span of 120 days.12,13 The characteristic biconcave shape
maximizes the surface area for oxygen exchange and enables
deformation for navigation through the smallest capillaries
with deformation depending on the diameter of the capillary
and the flow rate. Aging erythrocytes present abnormalities
in size and morphology due to changes in the cytoskeleton,
membrane, and/or precipitation of hemoglobin. Ultimately,
the reticulum endothelial system (RES) takes senescent eryth-
rocytes out of circulation.14,15 Thus, the “simple” architecture
of erythrocytes is, in fact, a complex network of mechanical,
chemical, and biological interactions determining cell survival.
Several mechanical, chemical, and electrical techniques have
been explored to load carrier erythrocytes for drug delivery and
as contrast agents for imaging.16 Changing erythrocytes’
osmotic conditions or inducing electrical breakdown drives
reversible pore formation, but under extreme conditions, it
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leads to lysis of the membrane.17 With stable pore formation,
diffusion allows entrance and exit through membrane pores
as equilibration with the external environment occurs.18–20
Procedures based on hypotonic conditions have been
explored for erythrosensor production.19,21,22 To date, research-
ers have studied hypotonic dialysis and hypotonic dilution to
produce erythrosensors.10,11 Variants of the hypotonic dialysis
technique, employing a dialysis tubing filled with erythrocytes
immersed in a hypotonic buffer, allow cargo diffusion through
the dialysis membrane and erythrocyte membrane for entrap-
ment, while the dialysis membrane maintains the erythrocytes
and hemoglobin concentration. Hypotonic dilution consists of
diluting erythrocytes in hypotonic solution to create pores
and quickly reseal the membrane using a hypertonic buffer at
37°C without the use of dialysis membrane. The change in
osmolarity creates pores through the erythrocyte membrane
and allows cargo loading as erythrocytes equilibrate with the
extracellular environment.23 These membrane pores allow rela-
tively large molecules to diffuse into the cells and generally lead
to ∼50% loading efficiency. Previous work has shown that the
emission spectrum of erythrosensors loaded with fluorescein
isothiocyanate conjugated with glycylglycine (FITC-glygly)
was equivalent to the emission by free FITC-glygly and was
able to track extracellular pH.11 Hypotonic dilution remains
the simplest and fastest loading technique. However, the result-
ing erythrosensor physical characteristics and cargo location
within the erythrocyte remain unknown.24,25
Electroporation is an alternative loading technique that
relies on short, intense electrical charges to create transmem-
brane pores and allow cargo entrance. Due to the membrane
potential difference and reversible electric breakdown, the
membrane phospholipid reassembles forming hydrophilic
pores.26 This technique is used for drug delivery and transfor-
mation/transfection applications because the pore size is tun-
able through electroporation conditions.27–29 Zimmermann
et al.30 showed data indicating that, although bovine erythro-
cytes have smaller diameter, they require higher field strength
for breakdown than human erythrocytes. At 0°C, the pores are
stable while increasing the temperature rapidly reseals the
membrane.31 Limitations associated with current techniques
include low encapsulation efficiency, nonuniform dye loading,
and loss of hemoglobin, which affect intrinsic cellular
functions.28 Under optimal conditions, erythrocytes loaded
using this technique have high cell recovery, maintain their
size and shape, and show normal in vivo circulation times.32
These attributes motivated the evaluation of electroporated
erythrocytes for use as erythrosensors.
Optimal long-term erythrosensors’ performance depends on
preserving erythrocyte properties while incorporating sensing
capabilities. The loss of hemoglobin during the loading process
leads to irreversible morphological changes.32–34 These morpho-
logical changes in erythrocytes can subsequently lead to
increased stiffness, halting their ability to squeeze through capil-
laries, and causing clogging as well as cellular removal.14
Furthermore, reports of carrier erythrocyte cellular modifica-
tions, leading to rapid clearance through the RES, a target
for drug delivery, and phagocytosis, have limited their imple-
mentation in other applications.14,15,35 Pathological and NEs
have been extensively studied using atomic-force microscopy
(AFM).36–38 Despite the advantages of using erythrocytes as car-
rier systems for optical sensors and drug delivery, little is known
about the cellular characteristics of the loaded cells.
Brähler et al.39 found that carrier erythrocytes with magnetite
cargo loaded via a hypoosmotic technique had a rugged cross-
section profile as evaluated via AFM. This data served as moti-
vation and a guide for continued comparative investigations of
the properties of NEs and erythrosensors using AFM. The work
described here offers insight into maximizing loading of an opti-
cally active cargo, FITC-glygly, into erythrocytes by optimizing
and implementing loading protocols. We focus on exploring the
loading impact on erythrosensors created via hypotonic dilution.
To understand the erythrosensors morphology, loading uniform-
ity, and volume-loading capacity, both confocal microscopy and
AFM are used. The cellular properties and the fluorescent signal
of two different loading procedures, hypotonic dilution and elec-
troporation, were evaluated (Fig. 1). Work in the drug delivery
field using erythrocytes has demonstrated that general loading
principles apply across species. For example, studies for the
encapsulation of L-asparaginase as a therapeutic molecule in
erythrocytes have been carried out in mice, monkeys, and
humans.40–42 Although the specifics of loading change slightly
with species, erythrocytes from different species respond to
osmolarity changes and electrical charges similarly. This
study investigates bovine erythrosensors as a model system
for carrying capabilities and identifies detrimental cellular mod-
ifications for long-term monitoring.
2 Materials and Methods
2.1 Fluorescein Isothiocianate-Glycylglycine
FITC was conjugated with glygly and used as cargo. FITC, a pH
sensitive dye used as a chemical sensor in biological materials,
has excitation and emission peaks at 492 and 518 nm, respec-
tively. This wavelength region facilitates fluorescence data col-
lection and study of the distribution within the erythrosensors.
As model cargo, the glygly addition makes FITC-glygly imper-
meable once encapsulated, preventing spontaneous leakage.
Moreover, FITC-glygly conjugate has been shown to conserve
its emission curve when encapsulated within erythrocytes.11
FITC and glygly were diluted in water at a 1:4 molar ratio
Fig. 1 Loading of erythrocytes via electroporation and dilution.
Isolated erythrocytes were subjected to either electroporation or hypo-
tonic dilution. Electroporation relies on the application of electrical
charges to disrupt the membrane potential, allowing cargo entrance
and requiring resealing to complete loading. Cells that underwent dilu-
tion are lysed and subsequently resealed to encapsulate cargo.
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for a final concentration of 5 mM FITC and 20 mM glygly at pH
9.0. Conjugation was achieved by mixing at room temperature
for 30 min. This preparation was made immediately before use
and maintained in the dark at 4°C. FITC and glygly were
obtained from Sigma-Aldrich.
2.2 Hypotonic Dilution
The temperature of hypotonic lysis buffer (10× solution consist-
ing of 10 mMMgCl2, 20 mM EDTA, 50 mM phosphate buffer,
and 1 mM urea) was lowered to 0°C to 2°C, and 1-ml FITC-
glygly at pH 9.0 was mixed in 25 ml of 1× hypotonic lysis buffer
(2.5 ml of 10× lysis buffer þ22.5 ml of deionized water).
Packed bovine erythrocytes (2 ml) were diluted in 25 ml of
the aqueous lysis solution with FITC-glygly and incubated
for 10 min. Then 2.5 ml of concentrated hypertonic lysis buffer
(10×) was added followed by incubation for 10 min at 0°C
before raising the temperature to 37°C and incubating for
30 min. To increase loading efficiency and generate more uni-
formly loaded erythrocytes, the solution was mixed throughout
the procedure and an extra centrifugation step to separate loaded
erythrosensors was introduced at the end of the procedure. Cells
were gently shaken throughout the process. The resultant sam-
ple pellet was washed with an isotonic buffer solution. To elimi-
nate FITC-glygly and debris aggregates, the sample was passed
through a 40-μm membrane and suspended at 50% hematocrit
(hct) for immediate analysis. To identify auto fluorescence,
erythrocytes were subjected to the hypotonic dilution procedure
without FITC-glygly (EH).
2.3 Electroporation
Packed erythrocytes (2 ml) were resuspended in 25 ml of elec-
troporation buffer. The temperature of packed erythrocytes was
lowered and maintained between 0°C and 4°C in order to expand
the lifetime of the transient pores formed. FITC-glygly was pre-
pared as before (5 mM FITC and 20 mM glygly), and just before
electroporation, 1 ml of FITC-glygly was added to the erythro-
cytes suspended in electroporation buffer. Then, the mixed
erythrocytes were aliquoted into electroporation 0.2 cm cuvettes
for 400 μl sample. Electroporation was performed using a Bio-
Rad Gene Pulser Xcell™ system at different electric fields (250,
300, and 750 V with a square-wave pulse ranging from 0.5 to
5 ms and the intervals of 5 to 15 min for a total of four cycles).
Cells were incubated for 10 min at 4°C after electroporation.
Then the samples were diluted 1:2 in resealing solution consist-
ing of 8 mM KCL (P9541-Sigma), 150 mM NaCl (s9888-
Sigma), 6 mM NaH2PO4 (s5011-Sigma), 10 mM D-Glucose
(g8270-Sigma), 2 mM MgCl2 (M8266-Sigma), and 1% bovine
serum albumin (BSA), pH 7.4. Resealing was promoted by
incubation at 37°C for 30 min, followed by an incubation at
4°C for 24 h. Loaded erythrocytes were washed with phosphate
buffer saline (PBS) by centrifugation and resuspended at 4°C at
an initial 50% hct. The sample was further diluted depending on
the experiment and analyzed immediately.
To control auto fluorescence, erythrocytes were electropo-
rated (EE) at 300 V amplitude and 1-ms pulse width without
FITC-glygly (fluorescent cargo), if a fluorescent signal in this
control indicates endogenous fluorescence. To identify sponta-
neous uptake of FITC-glygly, if any, a second control sample
was prepared, taking an aliquot of the mixed erythrocytes sus-
pended in electroporation buffer with FITC-glygly in an electro-
poration cuvette (the same volume as above) which was
incubated between 0°C and 4°C for the total time of electropo-
ration (35 to 95 min), but the samples were not electroporated.
Then, the samples were handled and evaluated just as the exper-
imental samples.
2.4 Fluorescence Microscopy
Following encapsulation, samples were suspended in 1% BSA
diluted in PBS for immediate imaging using a Nikon TE2000
epifluorescent microscope. Nikon blue excitation block B-2E/C
was used to excite FITC, which absorbs at 492 nm. A 5-μl sam-
ple was taken from a 25% hct sample and placed on a micro-
scope slide and covered with a 0.15-mm coverslip for imaging.
The corrected total cell fluorescence (CTCF) for the samples
was calculated using randomly selected cells from each
group (Electroporation 300 V, hypotonic dilution and controls).
Using ImageJ 1.48v5, the average cell and background fluores-
cence were used in the following equation:
EQ-TARGET;temp:intralink-;sec2.4;326;557
CTCF ¼ integrated density − ðarea of cell
×mean fluorescence of backgroundÞ:
Roundness was evaluated using ImageJ in which attributes
range from 0 (for an infinitely elongated polygon) to 1 (corre-
sponding to a perfect circle). As per condition, four images and a
total of 100 to 150 cells were evaluated. Analysis using ImageJ
was performed on uniform samples of randomly chosen cells for
each micrograph.
2.5 Confocal Microscopy
Erythrosensors loaded via hypotonic dilution and controls were
fixed in 0.025% glutaraldehyde to increase mechanical strength
and stability. Then, a 5 μl of 200 μl total sample recovered was
immobilized on a poly-L-lysine (PLL)-coated slide for imaging.
Confocal fluorescence microscopy was performed using
an Olympus FV1000 confocal microscope. A 100× objective
with a 1.4 numerical aperture was used to image the fluores-
cence emission under 488 nm (argon) laser excitation with
an emission filter at 505 to 575 nm. Planar images were
taken at 0.39 μm intervals through the sample sequentially.
Reconstruction and analysis of 3-D images were performed
using the standard Olympus FV10-ASW and Image J 1.48v5,
subsequently.
2.6 Spectrophotometry
Hemoglobin and FITC-glygly concentrations were determined
using the Hitachi U-4100 UV-vis-NIR spectrophotometer. The
absorbance of retained oxygenated hemoglobin was measured
in lysed NEs as control and erythrosensors samples (produced
via hypotonic dilution and electroporation) at 540 nm.
Absorbance measurements were recorded on the same day.
Samples (10% hct) were diluted to 1% hct in deionized water
and taken to 100% lysis. Referencing the hemoglobin concen-
tration in bovine blood ranges as 8 to 15 g∕dl, the absorbance
data from a pool of NE were calculated and a standard curve was
constructed.
2.7 Atomic Force Microscopy
To produce AFM topographical images of erythrosensors
and NEs, cells were fixed using 0.025% glutaraldehyde and
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immobilized on a PLL-coated glass slide. A Bruker Dimension
Icon AFM was used for scanning and obtaining topographical
images from erythrosensors and NEs. A diamond tapping tip
(Bruker tip MPP21000 RSFP 3 N∕m) and the ScanAsyst, an
image-optimization scanning mode, in tapping mode were
used to image the samples. Using ScanAsyst, the system con-
tinuously monitors image quality and makes parameter adjust-
ments to optimize image acquisition. This enables the mode to
operate at lower force than standard tapping mode and uses the
force curves as an imaging feedback signal. Erythrocytes are
delicate samples; hence, a combination of ScanAsyst (liquid)
and tapping mode (air) was used for AFM experiments to
minimize force applied to the sample. The scan size was
40 μm × 40 μm, the rate was 0.500 Hz, and there were
512 samples∕line. To quantify the surface roughness, the
mean of the absolute vertical deviation from the mean line of
the topographical profile, roughness average (Ra), was calcu-
lated. Briefly, a 1 μm × 1 μm section was chosen from six dif-
ferent topographical images (three NEs as control and three as
erythrosensors images). From each cell, three Ra values were
calculated and averaged using the Nanoscope software version
6.14.
3 Results
Electroporation loading of FITC-glygly into isolated bovine
erythrocytes was evaluated under different conditions.
Erythrocytes electroporated at 200, 300, and 750 V were found
to have average diameters of 4.37 μm% 0.54 stdev, 5.32 μm%
0.80 stdev, and 5.73 μm% 0.88 stdev, respectively (data not
shown). Electroporated at 300 V, erythrocytes maintained an
average diameter of 4.89 μm% 0.49, which lies in the lower
margin of the NE cell range. Although erythrocytes loaded
using a 750 V amplitude had a larger diameter size, they also
demonstrated a variation in size that could account for swollen
erythrocytes, lysed erythrocytes, and debris fragments.
Increasing the amplitude (200, 300, 400, 750, and 1000 V),
and thus the field of strength, decreased the hct of recovered
erythrosensors. Erythrosensors loaded via electroporation had
the highest fluorescence per cell when four 0.5-ms pulses of
300 Vamplitude were applied using a 0.2-cm cuvette, equivalent
to an electric field strength of 1.5 kV∕cm. These conditions
were used for the rest of the experiments.
Fluorescence micrographs were used to evaluate the relative
cell fluorescence from erythrosensors loaded via hypotonic dilu-
tion and electroporation (Fig. 2). Erythrocytes loaded via hypo-
tonic dilution had an average of four times more fluorescence
intensity than cells loaded using electroporation (P < 0.05).
Erythrocytes that go through the loading procedures (electropo-
ration or hypotonic dilution) lacking the fluorescent cargo
FITC-glygly did not display auto fluorescence. Neither EE
nor EH exhibited auto fluorescence associated with the opening
of pores via hypotonic dilution or electroporation. A circular
outline is seen in the fluorescent and bright-field micrographs
for erythrosensors resulting from both techniques, the hypotonic
dilution and electroporation. However, the erythrocytes charac-
teristic biconcave shape is not readily evident from the 20×
micrograph (Fig. 2). Additionally, fewer erythrocytes were
recovered after hypotonic dilution than after electroporation
with only 10% to 20% of the initial sample recovered using
hypotonic dilution, whereas 40% to 50% of the sample was
recovered using electroporation.
From the micrographs, the diameter and roundness were
evaluated in erythrosensors and compared with the values of
NEs (Fig. 3). Additionally, the hemoglobin retained was evalu-
ated in erythrosensors and compared with the values of NEs
using spectrophotometry (Fig. 3). Diameters were significantly
different among erythrosensors created by electroporation,
hypotonic dilution, and NEs as control. The average cell diam-
eter of the NEs measured 6.2 μm% 1.13 (average% stdev),
significantly greater than the published bovine erythrocytes’
diameter of 5.84 μm.12,43,44 The erythrocytes, which underwent
dilution and electroporation, measured 5.0 μm% 0.51 and
Fig. 2 Bovine erythrocytes loaded via either electroporation or dilution and fluorescence per cell revealed
as a measure of loading efficiency. Bright-field imaging shown on top and corresponding fluorescence
images shown below. Cell’s integrated density, area, and the mean fluorescence of the background were
used to evaluate the relative mean fluorescence signal per cell. Bars indicate standard deviation
(&P ≤ 0.05).
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5.32 μm% 0.80, respectively. In terms of roundness, there was
no significant difference between NEs as control and erythro-
sensors generated using electroporation or hypotonic dilution.
The roundness values for electroporated, dilution, and control
samples were 0.887% stdev 0.108, 0.908% stdev 0.052, and
0.909% 0.099, respectively. Bovine erythrocytes contain
between 8 and 15 g∕dL hemoglobin.12 The hemoglobin in
the NEs, as control samples, was estimated between 7 and
9 g∕dL, which correlates well with the values found in the
literature.12 The average hemoglobin concentration inside eryth-
rosensors loaded via electroporation was 5.63% 0.60 g∕dL.
Thus, electroporated erythrocytes lost ∼46% of their total
hemoglobin on average. The concentration of hemoglobin
inside the erythrosensors loaded via hypotonic dilution was
1.00% 0.56 g∕dL. Thus, erythrosensors produced via hypo-
tonic dilution lost ∼89% of their total hemoglobin content on
average. Although erythrosensors created using electroporation
retained higher concentrations of hemoglobin, both hypotonic
dilution and electroporation erythrosensors lost significant por-
tions of their hemoglobin. This loss could present a challenge to
the in vivo survival of erythrosensors.
The low loading efficiency of the electroporation technique
would make it difficult to develop an effective in vivo erythro-
sensor-based measurement system. Thus, confocal microscopy
was used to evaluate key population features in the erythrosen-
sors generated using hypotonic dilution. Confocal fluorescent
micrographs show nonuniform loading of the sample
(Fig. 4). A representative confocal Z-stack created using a step
size of 0.39 μm to evaluate the loading uniformity of the pop-
ulation and of the FITC-glygly entrapment. The sequential
images were processed to create the volumetric image and
then rotated 90 deg over the x-axis to reveal the distribution
of FITC-glygly. The 3-D images rendered insight into erythro-
sensors’ shape and demonstrated volume loading. In addition to
the erythrosensors distinctive round shape, the micrographs
revealed a population of erythrocytes with ∼30% loading effi-
ciency and a nonuniform fluorescence signal.
To further understand the changes in morphology, AFM was
used to study the topography and the cross-section profile of
NEs (control) and hypotonic dilution erythrosensors. AFM
results show a 10 μm × 10 μm area and the corresponding
topographical image [Fig. 5(a)]. Control erythrocytes exhibit
a characteristic shape and dimensions with a toroidal shape
with a 5.85 μm% 0.18 diameter. The hypotonic dilution
erythrosensors showed a corrugated, round, and flat shape
with a diameter of 5.30 μm% 1.63. Comparing the surface
profile of erythrocytes and erythrosensors revealed major mor-
phological changes. The highest peaks detected on the erythro-
sensors topography average 0.77 μm% 0.17 compared with
1.42 μm% 0.31 in the control. Erythrosensors, although similar
in diameter, had a greater variability in diameter and had a
height only half that of normal bovine erythrocytes.
The roughness of the topography of the control erythrocytes
and the erythrosensors exhibit differences in the topographical
images. The Ra value was found to be greater in erythrosensors
[Fig. 5(b)]. The surface roughness of erythrosensors, as
measured by the Ra value (0.2 nm), is ∼33% rougher than
the surface of NEs (0.14 nm). The evidence suggests that eryth-
rosensors loaded via hypotonic dilution exhibit morphological
changes that could compromise erythrosensor in vivo life span.
4 Discussion
In advance of employing erythrocytes as a sensor platform, we
explored erythrosensors’ fluorescent signal, dimensions,
Fig. 3 Characterization of erythrosensors size, shape, and hemoglobin retention compared with control
NEs. Hemoglobin concentration inside erythrosensors. Absorbance at 540 nm of hemoglobin in sample
of lyse control NEs, erythrosensors prepared using the hypotonic dilution and electroporation technique.
Bars indicate standard deviation (&P ≤ 0.05, & & & & P ≤ 0.0001).
Fig. 4 Confocal microscopy erythrosensors loaded via hypotonic
dilution technique entrapping FITC-glygly. (a) Volume rendering
sequence of FITC-glygly-loaded erythrosensors showing their spheri-
cal shape. (b) Representative micrographs of erythrosensors exhibit-
ing loading heterogeneity of the resulting population. Bright-field
imaging and fluorescence are shown at the top and the bottom,
respectively.
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morphology, and hemoglobin retention. These are essential fea-
tures to maintain erythrosensors in circulation for long-term
monitoring. Loading procedures were optimized around encap-
sulation of pH sensitive FITC-glygly in erythrocytes for both
hypotonic dilution and electroporation. Comparing these load-
ing techniques, erythrosensors produced via hypotonic dilution
resulted in higher loading efficiency. Higher loading of the opti-
cal sensor is crucial for providing sufficient optical signal for
long-term, noninvasive measurements based on erythrosensors
reinfused into circulation. The diameter of electroporated eryth-
rocytes (with and without FITC-glygly) is smaller when com-
pared with NEs likely due to the loss of cell content. This is
supported by the fact that erythrocytes electroporated with
cargo FITC-glygly (erythrosensors) have a larger diameter
than erythrocytes electroporated without FITC-glygly (EE).
When loading erythrocytes via electroporation, the cells main-
tained higher hemoglobin concentration than the dilution
method, but still lost approximately half of their total hemoglo-
bin. The loss of hemoglobin in both cases could be an impedi-
ment to erythrosensor survival in circulation. This study
suggests that hemoglobin levels and cargo loading concentra-
tions are inversely related. These findings are especially useful
as a basis to standardize the characterization erythrosensors for
use in an erythrosensor-based blood analyte monitoring system.
Erythrocytes loaded via hypotonic dilution and electropora-
tion maintained a rounded shape. Abnormal shapes indicate
cytoskeleton or membrane disruption or secondary issues
including precipitation of hemoglobin. Thus, the shape of the
erythrocyte and erythrosensors can be used as a marker of
functionality and integrity of the cell membrane and the cytos-
keleton. Our findings (i.e., misshape of erythrosensors and loss
of hemoglobin) suggest that an alternative loading to produce
erythrosensors that better mimic NEs must be found for
long-term monitoring.
One of the attributes of the erythrosensors loaded via hypo-
tonic dilution is the emission of a stronger fluorescent signal
when compared with electroporated erythrosensors, which moti-
vated the in-depth study of the hypotonic dilution loading tech-
nique. Further characterization of the fluorescence signal
emitted by FITC-glygly from erythrosensors resulting from
hypotonic dilution revealed a nonuniformly loaded population.
The use of an extra centrifugation step to further concentrate
loaded erythrosensors was established as a standard for the
study of erythrosensors via confocal microscopy and AFM.
Isolating erythrosensors with similar fluorescence increases
the chances that, for example during AFM topographical
images, the erythrosensors studied will be loaded with FITC-
glygly. Most importantly, it was demonstrated that the erythro-
sensors were volume loaded with FITC-glygly. Before this
study, the location of the cargo in carrier erythrocytes was
not well characterized. Although previous studies suggested
the entrapment of cargo, there was no conclusive evidence of
volume loading.10,11,35
Erythrosensors loaded via hypotonic dilution deformed, and
their surface topography became rugged. After verifying eryth-
rosensors’ integrity via AFM, it was confirmed that erythrosen-
sors loaded via hypotonic dilution lost the NE architecture
consistent with Brähler et al.'s39 findings, in which the cellular
Fig. 5 Erythrosensors’ topography reveals hills and valleys in their surface. (a) The height of the
erythrosensors shown in these images lies between 481 and 883 nm. (b) Ra value measuring the
mean of the absolute vertical deviation frommean line of the topographical profile. Bars indicate standard
deviation (&P ≤ 0.05).
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changes of carrier erythrocytes were first studied via AFM. The
use of AFM to characterize erythrosensors provided a route to
explore these changes in conjunction for fluorescence studies.
Here, the characterization of erythrosensors loaded using the
hypotonic dilution included the evaluation of size, morphology,
hemoglobin retention, and loading uniformity. Decreased size,
increased deformations, and rugged topography were some of
the erythrosensor attributes found here. The cellular artifacts
of carrier erythrocytes and erythrosensors were not well under-
stood and further exploration/optimization of the loading tech-
niques will be required to minimize cellular alterations and
potentially increase lifetime circulation as a long-term blood-
stream monitoring platform.
5 Conclusions
Because of their simplicity, biocompatibility, and biodegradabil-
ity, erythrocytes are an appealing platform for blood-based
delivery and monitoring. Erythrocytes depend on a variety of
properties including cell size, shape, and hemoglobin content
to fulfill their physiological roles. Although sensor functional-
ized erythrocytes, a.k.a. erythrosensors, offer an intriguing sol-
ution for long-term blood analyte monitoring, several factors
can influence the yield, integrity, and performance of the eryth-
rosensors. For example, the functionalization process could
have deleterious effects on cell structure and/or function.
Thus, the cellular properties of erythrosensors will impact
their functionality as a long-term monitoring platform.
This study sought deeper insight into cellular changes expe-
rienced by erythrosensors loaded via common techniques, hypo-
tonic dilution, and electroporation. Morphological changes in
erythrosensors and carrier erythrocytes after hypotonic dilution
and electroporation loading were previously not well investi-
gated. This study strove to develop protocols for the characteri-
zation of the physical properties of erythrosensors and identify
how erythrosensors differ from NEs. Although hypotonic dilu-
tion appears to load erythrosensors with sufficient cargo, the
identified cellular changes could jeopardize the erythrosensors’
ability to mimic NEs and function as a long-term sensor plat-
form in the bloodstream. From this study, neither hypotonic
dilution nor electroporation provide erythrosensors that pre-
cisely mimic erythrocytes. Therefore, this study provides a
step toward understanding the cellular properties of erythrosen-
sors and standardizing methodologies to assess carrier erythro-
cytes and erythrosensors.
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